普通会员
诚信认证:
工商注册信息已核实!
Varespladib
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
货号 | CAS号 | 操作 |
---|---|---|
V125011-5mg | 172732-68-2 | 询底价 |
V125011-10mg | 172732-68-2 | 询底价 |
V125011-50mg | 172732-68-2 | 询底价 |
属性
溶解性 |
|
存贮条件 | 储存温度-20°C |
描述
产品介绍 | Varespladib (LY315920)是一种有效的,选择性的human non-pancreatic secretory phospholipase A2 (hnsPLA)(人类非胰腺分泌型磷脂酶A2)抑制剂,IC50为7 nM。 |
备注 | LY315920 (Varespladib) is a potent and selective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor with IC50 of 7 nM,. Phase 3. |
生化机理 |
Varespladib (LY 315920), a specifically designed indolic secretory phospholipase A2 (sPLA2) inhibitor, has shown promising results in animals and adults. Inhibition seems to be inversely related to the severity of gas exchange impairment. Varespladib acts synergistically with pravastatin to decrease atherosclerosis, possibly through decreased levels of systemic inflammation or decreased lipid levels. Varespladib treatment also resulted in a profound increase in plasma PON activity and significantly larger fibrous caps, suggesting the formation of more stable plaque architecture. |
别名 | 伐瑞拉迪;LY-333013;[[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid;LY 315920;LY315920;LY-315920 |
Varespladib信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于Varespladib报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途